BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 12150905)

  • 1. Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy.
    Mankodi A; Takahashi MP; Jiang H; Beck CL; Bowers WJ; Moxley RT; Cannon SC; Thornton CA
    Mol Cell; 2002 Jul; 10(1):35-44. PubMed ID: 12150905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing.
    Charlet-B N; Savkur RS; Singh G; Philips AV; Grice EA; Cooper TA
    Mol Cell; 2002 Jul; 10(1):45-53. PubMed ID: 12150906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscle chloride channel dysfunction in two mouse models of myotonic dystrophy.
    Lueck JD; Mankodi A; Swanson MS; Thornton CA; Dirksen RT
    J Gen Physiol; 2007 Jan; 129(1):79-94. PubMed ID: 17158949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat.
    Mankodi A; Logigian E; Callahan L; McClain C; White R; Henderson D; Krym M; Thornton CA
    Science; 2000 Sep; 289(5485):1769-73. PubMed ID: 10976074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction of ClC-1 splicing eliminates chloride channelopathy and myotonia in mouse models of myotonic dystrophy.
    Wheeler TM; Lueck JD; Swanson MS; Dirksen RT; Thornton CA
    J Clin Invest; 2007 Dec; 117(12):3952-7. PubMed ID: 18008009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscleblind-Like 1 and Muscleblind-Like 3 Depletion Synergistically Enhances Myotonia by Altering Clc-1 RNA Translation.
    Choi J; Personius KE; DiFranco M; Dansithong W; Yu C; Srivastava S; Dixon DM; Bhatt DB; Comai L; Vergara JL; Reddy S
    EBioMedicine; 2015 Sep; 2(9):1034-47. PubMed ID: 26501102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A muscleblind knockout model for myotonic dystrophy.
    Kanadia RN; Johnstone KA; Mankodi A; Lungu C; Thornton CA; Esson D; Timmers AM; Hauswirth WW; Swanson MS
    Science; 2003 Dec; 302(5652):1978-80. PubMed ID: 14671308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy.
    Lin X; Miller JW; Mankodi A; Kanadia RN; Yuan Y; Moxley RT; Swanson MS; Thornton CA
    Hum Mol Genet; 2006 Jul; 15(13):2087-97. PubMed ID: 16717059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophy.
    Kanadia RN; Shin J; Yuan Y; Beattie SG; Wheeler TM; Thornton CA; Swanson MS
    Proc Natl Acad Sci U S A; 2006 Aug; 103(31):11748-53. PubMed ID: 16864772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Truncated ClC-1 mRNA in myotonic dystrophy exerts a dominant-negative effect on the Cl current.
    Berg J; Jiang H; Thornton CA; Cannon SC
    Neurology; 2004 Dec; 63(12):2371-5. PubMed ID: 15623702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA interference targeting CUG repeats in a mouse model of myotonic dystrophy.
    Sobczak K; Wheeler TM; Wang W; Thornton CA
    Mol Ther; 2013 Feb; 21(2):380-7. PubMed ID: 23183533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic exercise mitigates disease mechanisms and improves muscle function in myotonic dystrophy type 1 mice.
    Manta A; Stouth DW; Xhuti D; Chi L; Rebalka IA; Kalmar JM; Hawke TJ; Ljubicic V
    J Physiol; 2019 Mar; 597(5):1361-1381. PubMed ID: 30628727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional and post-transcriptional impact of toxic RNA in myotonic dystrophy.
    Osborne RJ; Lin X; Welle S; Sobczak K; O'Rourke JR; Swanson MS; Thornton CA
    Hum Mol Genet; 2009 Apr; 18(8):1471-81. PubMed ID: 19223393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daunorubicin reduces MBNL1 sequestration caused by CUG-repeat expansion and rescues cardiac dysfunctions in a
    Chakraborty M; Sellier C; Ney M; Pascal V; Charlet-Berguerand N; Artero R; Llamusi B
    Dis Model Mech; 2018 Apr; 11(4):. PubMed ID: 29592894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mice transgenic for the human myotonic dystrophy region with expanded CTG repeats display muscular and brain abnormalities.
    Seznec H; Agbulut O; Sergeant N; Savouret C; Ghestem A; Tabti N; Willer JC; Ourth L; Duros C; Brisson E; Fouquet C; Butler-Browne G; Delacourte A; Junien C; Gourdon G
    Hum Mol Genet; 2001 Nov; 10(23):2717-26. PubMed ID: 11726559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenic mice expressing CUG-BP1 reproduce splicing mis-regulation observed in myotonic dystrophy.
    Ho TH; Bundman D; Armstrong DL; Cooper TA
    Hum Mol Genet; 2005 Jun; 14(11):1539-47. PubMed ID: 15843400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy.
    Philips AV; Timchenko LT; Cooper TA
    Science; 1998 May; 280(5364):737-41. PubMed ID: 9563950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Misregulation of alternative splicing causes pathogenesis in myotonic dystrophy.
    Kuyumcu-Martinez NM; Cooper TA
    Prog Mol Subcell Biol; 2006; 44():133-59. PubMed ID: 17076268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac elav-type RNA-binding protein (ETR-3) binds to RNA CUG repeats expanded in myotonic dystrophy.
    Lu X; Timchenko NA; Timchenko LT
    Hum Mol Genet; 1999 Jan; 8(1):53-60. PubMed ID: 9887331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic therapy in an RNA toxicity mouse model with an antisense oligonucleotide therapy targeting a non-CUG sequence within the DMPK 3'UTR RNA.
    Yadava RS; Yu Q; Mandal M; Rigo F; Bennett CF; Mahadevan MS
    Hum Mol Genet; 2020 Jun; 29(9):1440-1453. PubMed ID: 32242217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.